August 8, 2023 07:00 AM EDT
Deals

Mer­ck en­lists As­tex to search for p53 can­cer drug in ex­pand­ed deal

Katherine Lewin

News Reporter

Mer­ck has ex­pand­ed its on­col­o­gy col­lab­o­ra­tion with Ot­su­ka sub­sidiary As­tex Phar­ma­ceu­ti­cals to the tune of a $35 mil­lion up­front pay­ment and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ideaya inks ADC deal with $75M up­front; Amy­lyx, Gubra to de­vel­op long-act­ing GLP-1

De­spite mixed da­ta in Alzheimer's ag­i­ta­tion, Ax­some will still seek FDA ap­proval

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

A service from the Financial Times